HIV-1 Vaccine Candidate Evaluation in Non-Human Primates

Publisher Website
Google Scholar
Abstract
The development of an HIV-1 vaccine in the last 13 years from an industrial point of view has focused on evaluating potential vaccine candidates in non-human primates. This review discusses the HJV-1 vaccine candidates that have been tested in chimpanzees or monkeys and includes those based on recombinant gpl20, recombinant gpl60, different viral and bacterial vectors expressing gpl20. gpl60, or only V3 peptide, naked DNA vaccines, and whole inactivated viruses. To help understand the result of efficacy studies in chimpanzees and monkeys, information regarding the challenge viruses used in these studies is also included. The review does not discuss the testing of SIV-related vaccines or the testing of HIV-1 vaccine candidates in other animal species other than non-human primates.

This publication has 0 references indexed in Scilit: